Glaxosmithkline Biologicals Company Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Summary for Glaxosmithkline Biologicals
Patents: | 0 |
Tradenames: | 14 |
Ingredients: | 14 |
BLAs: | 14 |
Biologic Drugs for Glaxosmithkline Biologicals
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Glaxosmithkline Biologicals | ENGERIX-B | hepatitis b vaccine (recombinant) | Injection | 103239 | 1989-08-28 | ⤷ Try a Trial | |
Glaxosmithkline Biologicals | HAVRIX | hepatitis a vaccine inactivated | Injection | 103475 | 1995-02-22 | ⤷ Try a Trial | |
Glaxosmithkline Biologicals | INFANRIX | diphtheria & tetanus toxoids & acellular pertussis vaccine adsorbed | Injection | 103647 | 1997-01-29 | ⤷ Try a Trial | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
This search can help find similar names.